Journal article
Mechanistic Target of Rapamycin Inhibition Prevents Coronary Artery Remodeling in a Murine Model of Kawasaki Disease
AT Stock, S Parsons, DB D'Silva, JA Hansen, VJ Sharma, F James, G Starkey, R D'Costa, CL Gordon, IP Wicks
Arthritis and Rheumatology | WILEY | Published : 2023
DOI: 10.1002/art.42340
Abstract
Objective: Remodeling of the coronary arteries is a common feature in severe cases of Kawasaki disease (KD). This pathology is driven by the dysregulated proliferation of vascular fibroblasts, which can lead to coronary artery aneurysms, stenosis, and myocardial ischemia. We undertook this study to investigate whether inhibiting fibroblast proliferation might be an effective therapeutic strategy to prevent coronary artery remodeling in KD. Method: We used a murine model of KD (induced by the injection of the Candida albicans water-soluble complex [CAWS]) and analyzed patient samples to evaluate potential antifibrotic therapies for KD. Results: We identified the mechanistic target of rapamyci..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
Supported by Victorian State Government Operational Infrastructure Support and the Australian Government National Health and Medical Research Council (NHMRC) Independent Research Institute Infrastructure Support scheme. Dr. Gordon's work was supported by the NHMRC Early Career Fellowship (grant 1160963). Dr. Wick's work was supported by the NHRMC Program (grant 1113577), a Clinical Practitioner Fellowship (award 1154235), and the Reid Charitable Trusts.